Skip to content
VuFind
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Cover Image

Saved in:
Bibliographic Details
Main Authors: Jean Galtier, Charles Mesguich, Pierre Sesques, Vivien Dupont, Emmanuel Bachy, Roberta Di Blasi, Catherine Thieblemont, Thomas Gastinne, Guillaume Cartron, Gabriel Brisou, François‐Xavier Gros, Justine Decroocq, Franck Morschhauser, Marie‐Thérèse Rubio, Laurianne Drieu La Rochelle, Fabien Le Bras, Sylvain Carras, Adrien Chauchet, Jacques‐Olivier Bay, Magalie Joris, Mickael Loschi, Aline Tanguy‐Schmidt, Alexandra Marquet, Vincent Camus, Steven Le Gouill, Roch Houot, Krimo Bouabdallah
Format: Artículo Open Access
Published: Wiley 2025
Subjects:
HemaSphere
Online Access:https://onlinelibrary.wiley.com/doi/10.1002/hem3.70091
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Table of Contents
  • Comments
  • Similar Items
  • Staff View

Internet

https://onlinelibrary.wiley.com/doi/10.1002/hem3.70091

Similar Items

  • Outcomes and treatment patterns of patients with primary mediastinal B‐cell lymphoma after CAR‐T cell therapy failure: A DESCAR‐T analysis
    by: Jean Galtier, et al.
    Published: (2025)
  • Outcomes and salvage strategies for large B‐cell lymphoma progressing after second‐line CAR T‐cell therapy: A DESCAR‐T study from the LYSA group
    by: Pierre Sesques, et al.
    Published: (2026)
  • 463 | ANTI‐CD19 CAR‐T CELL THERAPY IN RELAPSED/REFRACTORY T‐CELL/HISTIOCYTE‐RICH LARGE B‐CELL LYMPHOMA: INSIGHTS FROM THE FRENCH DESCAR‐T REGISTRY, A LYSA STUDY
    by: A. André, et al.
    Published: (2025)
  • 446 | IMPACT OF RESPONSE TO HOLDING/BRIDGING THERAPY IN SECOND‐LINE DLBCL PATIENTS TREATED WITH AXICABTAGENE CILOLEUCEL: A LYSA STUDY FROM THE FRENCH DESCAR‐T REGISTRY
    by: A. Capes, et al.
    Published: (2025)
  • 672 | REAL‐WORLD DATA OF LISOCABTAGENE MARALEUCEL AS SECOND LINE THERAPY FOR PATIENTS WITH LARGE B‐CELL LYMPHOMA: FIRST RESULTS OF THE FRENCH DESCAR‐T REGISTRY BY LYSA
    by: G. Brisou, et al.
    Published: (2025)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs